Clinical Trials Using Anti-AGS-8 Monoclonal Antibody AGS-8M4

Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-AGS-8 Monoclonal Antibody AGS-8M4. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis

    AL amyloidosis begins in the bone marrow where abnormal proteins misfold and create free light chains that cannot be broken down. These free light chains bind together to form amyloid fibrils that build up in the extracellular space of organs, affecting the kidneys, heart, liver, spleen, nervous system and digestive tract. The primary purpose of this study is to determine the recommended dose of CAEL-101 to facilitate progression of further clinical trials.
    Location: 2 locations